124 related articles for article (PubMed ID: 1449954)
21. High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease.
Jeon MJ; Lee Y; Ahn S; Lee C; Kim OH; Oh BC; Yu U; Kim H
Acta Radiol; 2015 Sep; 56(9):1051-60. PubMed ID: 25270373
[TBL] [Abstract][Full Text] [Related]
22. [Monitoring tumor response to therapy by means of 31P magnetic resonance spectroscopy. A case of advanced prostatic cancer with metastatic chest wall tumor].
Kaneko H; Nakauchi K; Mashima Y; Kawakami M; Kumakawa T
Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):819-22. PubMed ID: 8022147
[TBL] [Abstract][Full Text] [Related]
23. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report.
Narayan P; Jajodia P; Kurhanewicz J; Thomas A; MacDonald J; Hubesch B; Hedgcock M; Anderson CM; James TL; Tanagho EA
J Urol; 1991 Jul; 146(1):66-74. PubMed ID: 1711587
[TBL] [Abstract][Full Text] [Related]
24. 31P NMR spectroscopy of an experimentally induced intracerebral tumor in mice.
Ross BD; Higgins RJ; Conley FK; True NS
Magn Reson Med; 1987 Apr; 4(4):323-32. PubMed ID: 3586979
[TBL] [Abstract][Full Text] [Related]
25. Monitoring of tumor reoxygenation following irradiation by 31P magnetic resonance spectroscopy: an experimental study of human melanoma xenografts.
Olsen DR; Rofstad EK
Radiother Oncol; 1999 Sep; 52(3):261-7. PubMed ID: 10580874
[TBL] [Abstract][Full Text] [Related]
26. Differences in nucleotide compartmentation and energy state in isolated and in situ rat heart: assessment by 31P-NMR spectroscopy.
Williams JP; Headrick JP
Biochim Biophys Acta; 1996 Aug; 1276(1):71-9. PubMed ID: 8764892
[TBL] [Abstract][Full Text] [Related]
27. Growth of a spontaneous canine prostatic adenocarcinoma in vivo and in vitro: isolation and characterization of a neoplastic prostatic epithelial cell line, CPA 1.
Eaton CL; Pierrepoint CG
Prostate; 1988; 12(2):129-43. PubMed ID: 3368402
[TBL] [Abstract][Full Text] [Related]
28. An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors.
Harper ME; Goddard L; Glynne-Jones E; Wilson DW; Price-Thomas M; Peeling WB; Griffiths K
Prostate; 1993; 23(1):9-23. PubMed ID: 7687782
[TBL] [Abstract][Full Text] [Related]
29. Different energy metabolism in two human small cell lung cancer subpopulations examined by 31P magnetic resonance spectroscopy and biochemical analysis in vivo and in vitro.
Kristjansen PE; Spang-Thomsen M; Quistorff B
Cancer Res; 1991 Oct; 51(19):5160-4. PubMed ID: 1655247
[TBL] [Abstract][Full Text] [Related]
30. Phospholipid and energy metabolism of cancer cells monitored by 31P magnetic resonance spectroscopy: possible clinical significance.
Cohen JS
Mayo Clin Proc; 1988 Dec; 63(12):1199-207. PubMed ID: 3059078
[TBL] [Abstract][Full Text] [Related]
31. In Vitro
Sedivy P; Dusilova T; Hajek M; Burian M; Krššák M; Dezortova M
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946652
[TBL] [Abstract][Full Text] [Related]
32. Assessment of glucosylifosfamide mustard biodistribution in rats with prostate adenocarcinomas by means of in vivo 31P NMR and in vitro uptake experiments.
Haberkorn U; Krems B; Gerlach L; Bachert P; Morr I; Wiessler M; van Kaick G
Magn Reson Med; 1998 May; 39(5):754-61. PubMed ID: 9581607
[TBL] [Abstract][Full Text] [Related]
33. Radiation-induced changes in phosphorus T1 values in human melanoma xenografts studied by 31P-MRS.
Olsen DR; Petersen SB; Rofstad EK
Magn Reson Imaging; 1997; 15(10):1187-92. PubMed ID: 9408139
[TBL] [Abstract][Full Text] [Related]
34. 31P MRS of human tumor cells: effects of culture media and conditions on phospholipid metabolite concentrations.
Franks SE; Kuesel AC; Lutz NW; Hull WE
Anticancer Res; 1996; 16(3B):1365-74. PubMed ID: 8694503
[TBL] [Abstract][Full Text] [Related]
35. Changes in phosphatidylethanolamine metabolism in regenerating rat liver as measured by 31P-NMR.
Murphy EJ; Brindle KM; Rorison CJ; Dixon RM; Rajagopalan B; Radda GK
Biochim Biophys Acta; 1992 Apr; 1135(1):27-34. PubMed ID: 1591270
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo 1H and 31P magnetic resonance spectroscopy as a means for tumor characterization in ovarian cancer patients.
Abramov Y; Carmi S; Anteby SO; Ringel I
Oncol Rep; 2013 Jan; 29(1):321-8. PubMed ID: 23042519
[TBL] [Abstract][Full Text] [Related]
37. 31P spectroscopy of the human prostate gland in vivo using a transrectal probe.
Kurhanewicz J; Thomas A; Jajodia P; Weiner MW; James TL; Vigneron DB; Narayan P
Magn Reson Med; 1991 Dec; 22(2):404-13. PubMed ID: 1725918
[TBL] [Abstract][Full Text] [Related]
38. Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy.
Cornel EB; Smits GA; Oosterhof GO; Karthaus HF; Deburyne FM; Schalken JA; Heerschap A
J Urol; 1993 Dec; 150(6):2019-24. PubMed ID: 7693985
[TBL] [Abstract][Full Text] [Related]
39. The influence of medium formulation on phosphomonoester and UDP-hexose levels in cultured human colon tumor cells as observed by 31P NMR spectroscopy.
Shedd SF; Lutz NW; Hull WE
NMR Biomed; 1993; 6(4):254-63. PubMed ID: 8217527
[TBL] [Abstract][Full Text] [Related]
40. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review.
Kemp GJ; Meyerspeer M; Moser E
NMR Biomed; 2007 Oct; 20(6):555-65. PubMed ID: 17628042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
